These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 34108430)

  • 1. Time to Reconsider Monoamine Oxidase Inhibitors for Obsessive Compulsive Disorder?: A Case Series Using Phenelzine.
    Grant JE; Baldwin DS; Chamberlain SR
    J Clin Psychopharmacol; 2021 Jul-Aug 01; 41(4):461-464. PubMed ID: 34108430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoamine Oxidase Inhibitors for Trichotillomania: A Case Series.
    Grant JE; Chamberlain SR
    J Clin Psychopharmacol; 2023 Mar-Apr 01; 43(2):149-151. PubMed ID: 36700727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoamine oxidase inhibitors in obsessive-compulsive disorder.
    Jenike MA; Surman OS; Cassem NH; Zusky P; Anderson WH
    J Clin Psychiatry; 1983 Apr; 44(4):131-2. PubMed ID: 6833198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Placebo-controlled trial of fluoxetine and phenelzine for obsessive-compulsive disorder.
    Jenike MA; Baer L; Minichiello WE; Rauch SL; Buttolph ML
    Am J Psychiatry; 1997 Sep; 154(9):1261-4. PubMed ID: 9286186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MAOIs - does the evidence warrant their resurrection?
    Menkes D; Bosanac P; Castle D
    Australas Psychiatry; 2016 Aug; 24(4):371-3. PubMed ID: 26917855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Refractory depression treated with high doses of monoamine oxidase inhibitor.
    Guze BH; Baxter LR; Rego J
    J Clin Psychiatry; 1987 Jan; 48(1):31-2. PubMed ID: 3804984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A case report of leukopenia associated with phenelzine.
    Tipermas A; Gilman HE; Russakoff LM
    Am J Psychiatry; 1984 Jun; 141(6):806-7. PubMed ID: 6731626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The medical treatment of obsessive-compulsive disorder and anxiety.
    Bandelow B
    CNS Spectr; 2008 Sep; 13(9 Suppl 14):37-46. PubMed ID: 18849910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current place of monoamine oxidase inhibitors in the treatment of depression.
    Shulman KI; Herrmann N; Walker SE
    CNS Drugs; 2013 Oct; 27(10):789-97. PubMed ID: 23934742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoamine oxidase inhibitors and alprazolam in the treatment of panic disorder and agoraphobia.
    Sheehan DV
    Psychiatr Clin North Am; 1985 Mar; 8(1):49-62. PubMed ID: 2859580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Central nervous system toxicity after abrupt monoamine oxidase inhibitor switch: a case report.
    Safferman AZ; Masiar SJ
    Ann Pharmacother; 1992 Mar; 26(3):337-8. PubMed ID: 1554951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Five-year course of obsessive-compulsive disorder: predictors of remission and relapse.
    Eisen JL; Sibrava NJ; Boisseau CL; Mancebo MC; Stout RL; Pinto A; Rasmussen SA
    J Clin Psychiatry; 2013 Mar; 74(3):233-9. PubMed ID: 23561228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoamine Oxidase A Hypomethylation in Obsessive-Compulsive Disorder: Reversibility By Successful Psychotherapy?
    Schiele MA; Thiel C; Deckert J; Zaudig M; Berberich G; Domschke K
    Int J Neuropsychopharmacol; 2020 May; 23(5):319-323. PubMed ID: 32133483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A remarkable response of chronic severe obsessive-compulsive neurosis to phenelzine.
    Mahgoub OM
    Acta Psychiatr Scand; 1987 Feb; 75(2):222-3. PubMed ID: 3565070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination therapy with monoamine oxidase inhibitors and other antidepressants or stimulants: strategies for the management of treatment-resistant depression.
    Thomas SJ; Shin M; McInnis MG; Bostwick JR
    Pharmacotherapy; 2015 Apr; 35(4):433-49. PubMed ID: 25884531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Monoamine oxidase inhibitors in the treatment of obsessive disorders. Two case reports and review of the literature].
    Erfurth A; Schmauss M
    Nervenarzt; 1993 Jan; 64(1):70-2. PubMed ID: 8437650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Continuation and maintenance treatments in major depression: the neglected role of monoamine oxidase inhibitors.
    Kennedy SH
    J Psychiatry Neurosci; 1997 Mar; 22(2):127-31. PubMed ID: 9074307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The association between obsessive compulsive disorder and obsessive compulsive personality disorder: prevalence and clinical presentation.
    Gordon OM; Salkovskis PM; Oldfield VB; Carter N
    Br J Clin Psychol; 2013 Sep; 52(3):300-15. PubMed ID: 23865406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mood, personality disorder symptoms and disability in obsessive compulsive hoarders: a comparison with clinical and nonclinical controls.
    Frost RO; Steketee G; Williams LF; Warren R
    Behav Res Ther; 2000 Nov; 38(11):1071-81. PubMed ID: 11060936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Validation of a scale for responsibility (Salkovskis Responsibility Scale)].
    Bouvard M; Robbe-Grillet P; Milliery M; Pham S; Amireche S; Fanget F; Guerin J; Cottraux J
    Encephale; 2001; 27(3):229-37. PubMed ID: 11488253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.